美替拉酮治疗轻度自主皮质醇分泌的心血管效应:二次分析
结果显示卧位收缩压和舒张压下降、心外膜脂肪减少,醛固酮与血管紧张素II比值降低,而心脏功能与形态无变化。
要点
- 美替拉酮晚间给药12周可降低MACS患者卧位收缩压和舒张压。
- 治疗可减少心外膜脂肪,但心旁脂肪和心肌内脂肪无变化。
- 醛固酮与血管紧张素II比值下降,提示RAAS活性降低。
核心结论
- 晚间美替拉酮治疗改善MACS患者血压并减少心外膜脂肪组织。
研究设计与样本
- 前瞻性、开放标签、单中心研究的二次分析,纳入15例MACS患者(12例女性,年龄59[53-64]岁),在维也纳医科大学开展。
主要发现
- 心旁脂肪、心肌内脂肪以及心脏功能和形态未见变化。
临床怎么用
- 对于MACS患者,晚间美替拉酮治疗可能有助于改善血压和减少心外膜脂肪。
局限性
- 本研究为二次分析,样本量小(15例),且为开放标签、单中心设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Mild autonomous cortisol secretion (MACS) is associated with increased mortality, mainly because of cardiovascular disease. OBJECTIVE: Here we investigated the effects of cortisol-lowering medical treatment on blood pressure regulation, cardiac fat depots, heart function and morphology, and other cardiovascular risk factors. METHODS: In this secondary analysis of our prospective, open-label, single-center study at the Medical University of Vienna, we investigated 15 patients with MACS (12 women; age 59 [53-64] years) before and after 12 weeks of treatment with evening doses of metyrapone (500 mg at 6 Pm and 250 mg at 10 Pm). Cardiac fat stores, morphology, and myocardial function were evaluated using cardiac magnetic resonance imaging and spectroscopy. Orthostatic blood pressure regulation was measured by standardized protocols. Lipidomics, renin-angiotensin-aldosterone-system activity and branched-chain amino acid (BCAA) concentrations were assessed. RESULTS: Mean supine systolic (137 [121-139] vs 122 [115-129] mmHg; P = 0.041) and diastolic (89 [80-93] vs 75 [71-86] mmHg; P = .045) blood pressure decreased after treatment in patients without changes in concomitant antihypertensive medication. Epicardial fat was lower at follow-up compared to baseline (1032.70 [894.23-1482.90] vs 929.37 [736.12-1317.15] mm2; P = .022). No changes in paracardial and intramyocardial fat, as well as in cardiac function and morphology were observed. The aldosterone-to-angiotensin II ratio was lower at follow-up (1.56 [0.87-2.82] vs 1.21 [0.98-1.92]; P = .042) and alterations in lipid profiles, but not in BCAA levels, were identified. CONCLUSION: Treatment with evening doses of metyrapone improved blood pressure and reduced epicardial adipose tissue.
引用
- Niziolek H, Just I, Baumgartner C, et al. Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis. J Clin Endocrinol Metab. 2026. PMID: 42272038. doi:10.1210/clinem/dgag228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。